help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parma, J.
Right arrow Articles by Vassart, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parma, J.
Right arrow Articles by Vassart, G.
The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 8 2695-2701
Copyright © 1997 by The Endocrine Society

Endocrinological Oncology

Diversity and Prevalence of Somatic Mutations in the Thyrotropin Receptor and Gs{alpha} Genes as a Cause of Toxic Thyroid Adenomas1

Jasmine Parma2, Laurence Duprez2,3, Jacqueline Van Sande, Jacques Hermans, Pierre Rocmans, Guy Van Vliet, Sabine Costagliola, Patrice Rodien, Jacques E. Dumont and Gilbert Vassart

Institut de Recherche Interdisciplinaire (J.P., L.D., J.V.S., S.C., P.R., J.E.D., G.V.); Department of Medical Genetics (J.P., G.V.), Université Libre de Bruxelles, Campus Erasme, 1070 Bruxelles; Centre Hospitalier de Jolimont (J.H.), Haine-Saint-Paul, Belgium; Service de Chirurgie Thoracique (P.R.), Hôpital Erasme, 1070 Bruxelles; Service d’Endocrinologie (G.V.V.), Hôpital Sainte-Justine, Montréal, H3T 1C5 Québec, Canada

Address all correspondence and requests for reprints to: G. Vassart, I.R.I.B.H.N, Faculty of Medicine, University of Brussels, Campus Erasme, Route de Lennik 808, 1070 Brussels, Belgium. E-mail: gvassart{at}ulb.ac.be

A total of 33 different autonomous hot nodules from 31 patients, originating mainly from Belgium, were investigated for the presence of somatic mutations in the TSH receptor and Gs{alpha} genes. This constitutes an extension of our previous study, including the first 11 nodules of the series. The complete coding sequence of the TSH receptor gene and the segments of Gs{alpha} known to harbor mutations impairing guanosinetriphosphotase activity were studied by direct sequencing of genomic DNA extracted from the nodules. DNA from the juxtanodular tissue or peripheral white blood cells was analyzed in all patients to confirm that the mutations identified were somatic. Twenty-seven mutations (82%) were found in the TSH receptor gene, affecting a total of 12 different residues or locations. All these mutations but 2 (see below) have been identified previously as activating mutations. Only 2 mutations were found in Gs{alpha} (6%). In 4 nodules, no mutation was detected. Five residues (Ser281, Ile486, Ile568, Phe631, and Asp633) were found mutated in 3 or 4 different nodules, making them hot spots for activating mutations. Phe631 and Asp633 belong to a cluster of 5 consecutive residues (629–633) in the N-terminal half of transmembrane segment VI, which harbor together 44% of the mutations identified in this cohort. Two novel mutations were identified: a point mutation causing substitution of Phe for Leu at position 629 (L629F); and a deletion of 12 bases removing residues 658–661 at the C-terminal portion of exoloop 3 (del658–661). When tested by transfection in COS-7 cells, both mutant receptors display increase in constitutive stimulation of basal cAMP accumulation. Although it is still capable of binding TSH, the del658–661 mutant has completely lost the ability to respond to the stimulation by the hormone. Our results demonstrate that, in a cohort of patients from a moderately iodine deficient area, somatic mutations increasing the constitutive activity of the TSH receptor are the major cause of autonomous hot nodules.




This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
F Palos-Paz, O Perez-Guerra, J Cameselle-Teijeiro, C Rueda-Chimeno, F Barreiro-Morandeira, J Lado-Abeal, the Galician Group for the Study of Toxic Multinod, D Araujo Vilar, R Argueso, O Barca, et al.
Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain
Eur. J. Endocrinol., November 1, 2008; 159(5): 623 - 631.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Eszlinger, K. Krohn, S. Hauptmann, H. Dralle, T. J. Giordano, and R. Paschke
Perspectives for Improved and More Accurate Classification of Thyroid Epithelial Tumors
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3286 - 3294.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. R. H. Buch, H. Biebermann, H. Kalwa, O. Pinkenburg, D. Hager, H. Barth, K. Aktories, A. Breit, and T. Gudermann
G13-dependent Activation of MAPK by Thyrotropin
J. Biol. Chem., July 18, 2008; 283(29): 20330 - 20341.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Moreno-Reyes, B.-N.-T. Tang, A. Seret, S. Goldman, C. Daumerie, and B. Corvilain
Impaired Iodide Organification in Autonomous Thyroid Nodules
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4719 - 4724.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. C. Moeller, M. Alonso, X. Liao, V. Broach, A. Dumitrescu, J. Van Sande, L. Montanelli, S. Skjei, C. Goodwin, H. Grasberger, et al.
Pituitary-Thyroid Setpoint and Thyrotropin Receptor Expression in Consomic Rats
Endocrinology, October 1, 2007; 148(10): 4727 - 4733.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M.-F. van den Hove, K. Croizet-Berger, D. Tyteca, C. Selvais, P. de Diesbach, and P. J. Courtoy
Thyrotropin Activates Guanosine 5'-Diphosphate/Guanosine 5'-Triphosphate Exchange on the Rate-Limiting Endocytic Catalyst, Rab5a, in Human Thyrocytes in Vivo and in Vitro
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2803 - 2810.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
S.-C. Ho, S.-S. Goh, I. H C Kee, P. K H Chow, C.-P. Yeo, and D. H C Khoo
Effects of genetic immunization of Swiss outbred mice with human thyroid stimulating hormone receptor cDNA plasmids harboring gain-of-function mutations
J. Mol. Endocrinol., February 1, 2007; 38(2): 277 - 288.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
H. I. Gozu, R. Bircan, K. Krohn, S. Muller, S. Vural, C. Gezen, H. Sargin, D. Yavuzer, M. Sargin, B. Cirakoglu, et al.
Similar prevalence of somatic TSH receptor and Gs{alpha} mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey.
Eur. J. Endocrinol., October 1, 2006; 155(4): 535 - 545.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. Van Durme, F. Horn, S. Costagliola, G. Vriend, and G. Vassart
GRIS: Glycoprotein-Hormone Receptor Information System
Mol. Endocrinol., September 1, 2006; 20(9): 2247 - 2255.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. S. Alzahrani, E. Y. Baitei, M. Zou, and Y. Shi
Metastatic Follicular Thyroid Carcinoma Arising from Congenital Goiter as a Result of a Novel Splice Donor Site Mutation in the Thyroglobulin Gene
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 740 - 746.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
W. C. G. van Staveren, D. W. Solis, L. Delys, D. Venet, M. Cappello, G. Andry, J. E. Dumont, F. Libert, V. Detours, and C. Maenhaut
From The Cover: Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis
PNAS, January 10, 2006; 103(2): 413 - 418.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
S G Watson, A D Radford, A Kipar, P Ibarrola, and L Blackwood
Somatic mutations of the thyroid-stimulating hormone receptor gene in feline hyperthyroidism: parallels with human hyperthyroidism
J. Endocrinol., September 1, 2005; 186(3): 523 - 537.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
K. Krohn, D. Fuhrer, Y. Bayer, M. Eszlinger, V. Brauer, S. Neumann, and R. Paschke
Molecular Pathogenesis of Euthyroid and Toxic Multinodular Goiter
Endocr. Rev., June 1, 2005; 26(4): 504 - 524.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
V. Porra, C. Ferraro-Peyret, C. Durand, S. Selmi-Ruby, H. Giroud, N. Berger-Dutrieux, M. Decaussin, J.-L. Peix, C. Bournaud, J. Orgiazzi, et al.
Silencing of the Tumor Suppressor Gene SLC5A8 Is Associated with BRAF Mutations in Classical Papillary Thyroid Carcinomas
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3028 - 3035.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Urizar, S. Claeysen, X. Deupi, C. Govaerts, S. Costagliola, G. Vassart, and L. Pardo
An Activation Switch in the Rhodopsin Family of G Protein-coupled Receptors: THE THYROTROPIN RECEPTOR
J. Biol. Chem., April 29, 2005; 280(17): 17135 - 17141.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
S. Neumann, M. Claus, and R. Paschke
Interactions between the extracellular domain and the extracellular loops as well as the 6th transmembrane domain are necessary for TSH receptor activation
Eur. J. Endocrinol., April 1, 2005; 152(4): 625 - 634.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
F Al-Khafaji, M Wiltshire, D Fuhrer, G Mazziotti, M D Lewis, P J Smith, and M Ludgate
Biological activity of activating thyrotrophin receptor mutants: modulation by iodide
J. Mol. Endocrinol., February 1, 2005; 34(1): 209 - 220.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
L. Montanelli, J. J. J. Van Durme, G. Smits, M. Bonomi, P. Rodien, E. J. Devor, K. Moffat-Wilson, L. Pardo, G. Vassart, and S. Costagliola
Modulation of Ligand Selectivity Associated with Activation of the Transmembrane Region of the Human Follitropin Receptor
Mol. Endocrinol., August 1, 2004; 18(8): 2061 - 2073.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
P. Rodien, N. Jordan, A. Lefevre, J. Royer, C. Vasseur, F. Savagner, A. Bourdelot, and V. Rohmer
Abnormal stimulation of the thyrotrophin receptor during gestation
Hum. Reprod. Update, March 1, 2004; 10(2): 95 - 105.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J.-C. Goffard, L. Jin, H. Mircescu, P. Van Hummelen, C. Ledent, J.-E. Dumont, and B. Corvilain
Gene Expression Profile in Thyroid of Transgenic Mice Overexpressing the Adenosine Receptor 2a
Mol. Endocrinol., January 1, 2004; 18(1): 194 - 213.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Als, P. Gedeon, H. Rosler, C. Minder, P. Netzer, and J. A. Laissue
Survival Analysis of 19 Patients with Toxic Thyroid Carcinoma
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4122 - 4127.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. Croizet-Berger, C. Daumerie, M. Couvreur, P. J. Courtoy, and M.-F. van den Hove
The endocytic catalysts, Rab5a and Rab7, are tandem regulators of thyroid hormone production
PNAS, June 11, 2002; 99(12): 8277 - 8282.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Alberti, M. C. Proverbio, S. Costagliola, R. Romoli, B. Boldrighini, M. C. Vigone, G. Weber, G. Chiumello, P. Beck-Peccoz, and L. Persani
Germline Mutations of TSH Receptor Gene as Cause of Nonautoimmune Subclinical Hypothyroidism
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2549 - 2555.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. A. Fagin
Minireview: Branded from the Start--Distinct Oncogenic Initiating Events May Determine Tumor Fate in the Thyroid
Mol. Endocrinol., May 1, 2002; 16(5): 903 - 911.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
V. Vlaeminck-Guillem, S.-C. Ho, P. Rodien, G. Vassart, and S. Costagliola
Activation of the cAMP Pathway by the TSH Receptor Involves Switching of the Ectodomain from a Tethered Inverse Agonist to an Agonist
Mol. Endocrinol., April 1, 2002; 16(4): 736 - 746.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. Neumann, G. Krause, S. Chey, and R. Paschke
A Free Carboxylate Oxygen in the Side Chain of Position 674 in Transmembrane Domain 7 Is Necessary for TSH Receptor Activation
Mol. Endocrinol., August 1, 2001; 15(8): 1294 - 1305.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Krohn and R. Paschke
Progress in Understanding the Etiology of Thyroid Autonomy
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3336 - 3345.
[Full Text] [PDF]

Home page
 EndocrinologyHome page
S. C. Ho, J. Van Sande, A. Lefort, G. Vassart, and S. Costagliola
Effects of Mutations Involving the Highly Conserved S281HCC Motif in the Extracellular Domain of the Thyrotropin (TSH) Receptor on TSH Binding and Constitutive Activity
Endocrinology, July 1, 2001; 142(7): 2760 - 2767.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Murakami, O. Araki, Y. Hosoi, Y. Kamiya, T. Morimura, T. Ogiwara, H. Mizuma, and M. Mori
Expression and Regulation of Type II Iodothyronine Deiodinase in Human Thyroid Gland
Endocrinology, July 1, 2001; 142(7): 2961 - 2967.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
P. M. Yen
Physiological and Molecular Basis of Thyroid Hormone Action
Physiol Rev, July 1, 2001; 81(3): 1097 - 1142.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. D. Wilson
Prospects for Research for Disorders of the Endocrine System
JAMA, February 7, 2001; 285(5): 624 - 627.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Mühlberg, K. Herrmann, W. Joba, M. Kirchberger, H.-J. Heberling, and A. E. Heufelder
Lack of Association of Nonautoimmune Hyperfunctioning Thyroid Disorders and a Germline Polymorphism of Codon 727 of the Human Thyrotropin Receptor in a European Caucasian Population
J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2640 - 2643.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Persani, A. Lania, L. Alberti, R. Romoli, G. Mantovani, S. Filetti, A. Spada, and M. Conti
Induction of Specific Phosphodiesterase Isoforms by Constitutive Activation of the cAMP Pathway in Autonomous Thyroid Adenomas
J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2872 - 2878.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
S. Y. Hsu, M. Kudo, T. Chen, K. Nakabayashi, A. Bhalla, P. J. van der Spek, M. van Duin, and A. J. W. Hsueh
The Three Subfamilies of Leucine-Rich Repeat-Containing G Protein-Coupled Receptors (LGR): Identification of LGR6 and LGR7 and the Signaling Mechanism for LGR7
Mol. Endocrinol., August 1, 2000; 14(8): 1257 - 1271.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Tonacchera, P. Agretti, L. Chiovato, V. Rosellini, G. Ceccarini, A. Perri, P. Viacava, A. G. Naccarato, P. Miccoli, A. Pinchera, et al.
Activating Thyrotropin Receptor Mutations Are Present in Nonadenomatous Hyperfunctioning Nodules of Toxic or Autonomous Multinodular Goiter
J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2270 - 2274.
[Abstract] [Full Text]

Home page
 NEJMHome page
G. Liu, L. Duranteau, J.-C. Carel, J. Monroe, D. A. Doyle, and A. Shenker
Leydig-Cell Tumors Caused by an Activating Mutation of the Gene Encoding the Luteinizing Hormone Receptor
N. Engl. J. Med., December 2, 1999; 341(23): 1731 - 1736.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. H. C. Khoo, J. Parma, C. Rajasoorya, S. C. Ho, and G. Vassart
A Germline Mutation of the Thyrotropin Receptor Gene Associated with Thyrotoxicosis and Mitral Valve Prolapse in a Chinese Family
J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1459 - 1462.
[Abstract] [Full Text]

Home page
 NEJMHome page
P. Rodien, C. Bremont, M.-L. R. Sanson, J. Parma, J. Van Sande, S. Costagliola, J.-P. Luton, G. Vassart, and L. Duprez
Familial Gestational Hyperthyroidism Caused by a Mutant Thyrotropin Receptor Hypersensitive to Human Chorionic Gonadotropin
N. Engl. J. Med., December 17, 1998; 339(25): 1823 - 1826.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
X. De Deken, C. Vilain, J. Van Sande, J. E. Dumont, and F. Miot
Decrease of Telomere Length in Thyroid Adenomas without Telomerase Activity
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4368 - 4372.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Rodien, F. Cetani, S. Costagliola, M. Tonacchera, L. Duprez, T. Minegishi, C. Govaerts, and G. Vassart
Evidences for an Allelic Variant of the Human LC/CG Receptor rather than a Gene Duplication: Functional Comparison of Wild-Type and Variant Receptors
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4431 - 4434.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. L. Sugg, S. Ezzat, I. B. Rosen, J. L. Freeman, and S. L. Asa
Distinct Multiple RET/PTC Gene Rearrangements in Multifocal Papillary Thyroid Neoplasia
J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4116 - 4122.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
O. Chabre, P. Liakos, J. Vivier, P. Chaffanjon, F. Labat-Moleur, M. Martinie, S. P. Bottari, I. Bachelot, E. M. Chambaz, G. Defaye, et al.
Cushing's Syndrome due to a Gastric Inhibitory Polypeptide-Dependent Adrenal Adenoma: Insights into Hormonal Control of Adrenocortical Tumorigenesis
J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3134 - 3143.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Lania, L. Persani, E. Ballaré, S. Mantovani, M. Losa, and A. Spada
Constitutively Active Gs{alpha} Is Associated with an Increased Phosphodiesterase Activity in Human Growth Hormone-Secreting Adenomas
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1624 - 1628.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Tonacchera, L. Chiovato, A. Pinchera, P. Agretti, E. Fiore, F. Cetani, R. Rocchi, P. Viacava, P. Miccoli, and P. Vitti
Hyperfunctioning Thyroid Nodules in Toxic Multinodular Goiter Share Activating Thyrotropin Receptor Mutations with Solitary Toxic Adenoma
J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 492 - 498.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
S. Costagliola, P. Rodien, M.-C. Many, M. Ludgate, and G. Vassart
Genetic Immunization Against the Human Thyrotropin Receptor Causes Thyroiditis and Allows Production of Monoclonal Antibodies Recognizing the Native Receptor
J. Immunol., February 1, 1998; 160(3): 1458 - 1465.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. Paschke and M. Ludgate
The Thyrotropin Receptor in Thyroid Diseases
N. Engl. J. Med., December 4, 1997; 337(23): 1675 - 1681.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H.-P. Holzapfel, D. Fuhrer, P. Wonerow, G. Weinland, W. A. Scherbaum, and R. Paschke
Identification of Constitutively Activating Somatic Thyrotropin Receptor Mutations in a Subset of Toxic Multinodular Goiters
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4229 - 4233.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Nakabayashi, M. Kudo, B. Kobilka, and A. J. W. Hsueh
Activation of the Luteinizing Hormone Receptor Following Substitution of Ser-277 with Selective Hydrophobic Residues in the Ectodomain Hinge Region
J. Biol. Chem., September 22, 2000; 275(39): 30264 - 30271.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Govaerts, A. Lefort, S. Costagliola, S. J. Wodak, J. A. Ballesteros, J. Van Sande, L. Pardo, and G. Vassart
A Conserved Asn in Transmembrane Helix 7 Is an On/Off Switch in the Activation of the Thyrotropin Receptor
J. Biol. Chem., June 15, 2001; 276(25): 22991 - 22999.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society